Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Prince

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Annals of the Rheumatic Diseases|July 8, 2009
Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritisF H M Prince, L M Geerdink, G J J M Borsboom, et al.
Annals of the Rheumatic Diseases|January 24, 2012
The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritisDirk Holzinger, Michael Frosch, Astrid Kastrup, et al.
The Journal of Rheumatology|January 17, 2018
S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic ArthritisFaekah Gohar, Janneke Anink, Halima Moncrieffe, et al.
Plos One|August 15, 2019
Correction: Prevalence and predictors for sustained remission in rheumatoid arthritisYoon-Kyoung Sung, Kazuki Yoshida, Femke H M Prince, et al.
Plos One|April 20, 2019
Prevalence and predictors for sustained remission in rheumatoid arthritisYoon-Kyoung Sung, Kazuki Yoshida, Femke H M Prince, et al.
JAMA|November 8, 2011
Factors associated with treatment response to etanercept in juvenile idiopathic arthritisMarieke H Otten, Femke H M Prince, Wineke Armbrust, et al.
Gene Therapy|March 29, 2008
Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in miceJ A Westwood, W K Murray, M Trivett, et al.
The Journal of Rheumatology|August 17, 2011
Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010Marieke H Otten, Femke H M Prince, Marinka Twilt, et al.
Arthritis Research & Therapy|August 8, 2015
MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritisJanneke Anink, Lisette W A Van Suijlekom-Smit, Marieke H Otten, et al.
Arthritis and Rheumatism|February 1, 2011
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter seriesPeter A Nigrovic, Melissa Mannion, Femke H M Prince, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Annals of the Rheumatic Diseases|July 8, 2009
Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritisF H M Prince, L M Geerdink, G J J M Borsboom, et al.
Annals of the Rheumatic Diseases|January 24, 2012
The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritisDirk Holzinger, Michael Frosch, Astrid Kastrup, et al.
The Journal of Rheumatology|January 17, 2018
S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic ArthritisFaekah Gohar, Janneke Anink, Halima Moncrieffe, et al.
Plos One|August 15, 2019
Correction: Prevalence and predictors for sustained remission in rheumatoid arthritisYoon-Kyoung Sung, Kazuki Yoshida, Femke H M Prince, et al.
Plos One|April 20, 2019
Prevalence and predictors for sustained remission in rheumatoid arthritisYoon-Kyoung Sung, Kazuki Yoshida, Femke H M Prince, et al.
JAMA|November 8, 2011
Factors associated with treatment response to etanercept in juvenile idiopathic arthritisMarieke H Otten, Femke H M Prince, Wineke Armbrust, et al.
Gene Therapy|March 29, 2008
Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in miceJ A Westwood, W K Murray, M Trivett, et al.
The Journal of Rheumatology|August 17, 2011
Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010Marieke H Otten, Femke H M Prince, Marinka Twilt, et al.
Arthritis Research & Therapy|August 8, 2015
MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritisJanneke Anink, Lisette W A Van Suijlekom-Smit, Marieke H Otten, et al.
Arthritis and Rheumatism|February 1, 2011
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter seriesPeter A Nigrovic, Melissa Mannion, Femke H M Prince, et al.
Pageof 16